- Home
- GRWG vs CRBP Comparison
GRWG vs CRBP Comparison
Compare GRWG & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRWG
- CRBP
- Stock Information
- Founded
- GRWG 2008
- CRBP 2009
- Country
- GRWG United States
- CRBP United States
- Employees
- GRWG N/A
- CRBP N/A
- Industry
- GRWG RETAIL: Building Materials
- CRBP Biotechnology: Pharmaceutical Preparations
- Sector
- GRWG Consumer Discretionary
- CRBP Health Care
- Exchange
- GRWG Nasdaq
- CRBP Nasdaq
- Market Cap
- GRWG 98.0M
- CRBP 110.3M
- IPO Year
- GRWG N/A
- CRBP N/A
- Fundamental
- Price
- GRWG $1.77
- CRBP $9.79
- Analyst Decision
- GRWG Strong Buy
- CRBP Strong Buy
- Analyst Count
- GRWG 1
- CRBP 10
- Target Price
- GRWG $2.50
- CRBP $53.22
- AVG Volume (30 Days)
- GRWG 882.7K
- CRBP 107.9K
- Earning Date
- GRWG 08-11-2025
- CRBP 08-05-2025
- Dividend Yield
- GRWG N/A
- CRBP N/A
- EPS Growth
- GRWG N/A
- CRBP N/A
- EPS
- GRWG N/A
- CRBP N/A
- Revenue
- GRWG $164,108,000.00
- CRBP N/A
- Revenue This Year
- GRWG N/A
- CRBP N/A
- Revenue Next Year
- GRWG N/A
- CRBP $270.04
- P/E Ratio
- GRWG N/A
- CRBP N/A
- Revenue Growth
- GRWG N/A
- CRBP N/A
- 52 Week Low
- GRWG $0.82
- CRBP $4.64
- 52 Week High
- GRWG $2.33
- CRBP $61.89
- Technical
- Relative Strength Index (RSI)
- GRWG 77.17
- CRBP 62.32
- Support Level
- GRWG $1.45
- CRBP $8.88
- Resistance Level
- GRWG $1.64
- CRBP $9.59
- Average True Range (ATR)
- GRWG 0.13
- CRBP 0.59
- MACD
- GRWG 0.05
- CRBP 0.03
- Stochastic Oscillator
- GRWG 97.47
- CRBP 78.45
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.